COVID-19

This test uses two SARS-CoV-2 primer and probe sets to detect regions in the N gene of SARS-CoV-2 from respiratory or nasal samples.

In vitro quantitative determination of COVID-19 nucleoprotein concentrations in plasma, tissue homogenates and other biological fluids from various mammalian species.

In vitro quantitative determination of anti-SARS-CoV2 IgM concentrations from human samples of plasma, tissue homogenates and other biological fluids.

In vitro quantitative determination of anti-SARS-CoV2 IgG concentrations from human samples of plasma, tissue homogenates and other biological fluids.

Designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma or whole blood.

Recombinant His-tagged human ACE2 (Met1-Ser740) with polyhistidine tag at the N- and C-terminus. Expressed in E. coli.

Monoclonal antibody raised against the coronavirus spike S2 (B) protein, a common target for neutralizing antibodies and vaccines.

Monoclonal antibody raised against the coronavirus spike S2 protein, a common target for neutralizing antibodies and vaccines.

Monoclonal antibody raised against the coronavirus spike S2 protein, a common target for neutralizing antibodies and vaccines.

Monoclonal antibody raised against the coronavirus spike S1 protein, a common target for neutralizing antibodies and vaccines.

Monoclonal antibody raised against the coronavirus spike S1 protein, a common target for neutralizing antibodies and vaccines.

Recombinant His-tagged SARS-CoV-2 Nucleocapsid protein, with polyhistidine tag at the N- and C-terminus. Expressed in E. coli.